Open | - |
Close | - |
Volume / Avg. | 0 / 653.179K |
Day Range | - - - |
52 Wk Range | 17.685 - 40.420 |
Market Cap | $1.794B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | % |
Days to Cover | 6.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zai Lab (NASDAQ: ZLAB) through any online brokerage.
Other companies in Zai Lab’s space includes: Twist Bioscience (NASDAQ:TWST), Gyre Therapeutics (NASDAQ:GYRE), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Zai Lab (NASDAQ: ZLAB) was reported by Citigroup on Thursday, February 29, 2024. The analyst firm set a price target for 66.00 expecting ZLAB to rise to within 12 months (a possible 265.04% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Zai Lab (NASDAQ: ZLAB) is $18.08 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Zai Lab.
Zai Lab’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Zai Lab.
Zai Lab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.